Super-precise CRISPR tool enters US clinical trials for the first time But an array of improved genome-editing methods promises many treatment options beyond classic CRISPR–Cas9. “It’s like ...

Machine learning models have seeped into the fabric of our lives, from curating playlists to explaining hard concepts in a ...

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its ...

The therapy uses a form of CRISPR—delivered to his liver cells ... The researchers believe their approach can be tweaked to treat a wide array of ultra-rare genetic diseases.

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

The advanced system, to be housed at Lawrence Berkeley National Laboratory and scheduled to become operational in 2026, will ...

Stanford scientists used machine learning to design improved zinc fingers that target disease genes while minimizing immunogenicity risk.

The global sales of DNA polymerase are estimated to be worth USD 397.7 million in 2025 and anticipated to reach a value of USD 725.8 million by 2035. Sales are projected to rise at a CAGR of 6.2% over ...

Beyond human health, biotechnology is fundamental to securing our food future ...